217 related articles for article (PubMed ID: 15280532)
41. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17.
Cannon PM; Matthews S; Clark N; Byles ED; Iourin O; Hockley DJ; Kingsman SM; Kingsman AJ
J Virol; 1997 May; 71(5):3474-83. PubMed ID: 9094619
[TBL] [Abstract][Full Text] [Related]
42. Role of myristylation in HIV-1 Gag assembly.
Bouamr F; Scarlata S; Carter C
Biochemistry; 2003 Jun; 42(21):6408-17. PubMed ID: 12767222
[TBL] [Abstract][Full Text] [Related]
43. The matrix domain of the Gag protein from avian sarcoma virus contains a PI(4,5)P
Watanabe SM; Medina GN; Eastep GN; Ghanam RH; Vlach J; Saad JS; Carter CA
J Biol Chem; 2018 Dec; 293(49):18841-18853. PubMed ID: 30309982
[TBL] [Abstract][Full Text] [Related]
44. Interferon-gamma is associated with the surface of the human immunodeficiency virus and binds to the gag gene product p17.
Caruso A; Pollara P; Foresti I; Bonfanti C; De Francesco M; Gelmi M; Turano A
AIDS Res Hum Retroviruses; 1989 Dec; 5(6):605-12. PubMed ID: 2514776
[TBL] [Abstract][Full Text] [Related]
45. Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17.
Izumi Y; Watanabe H; Watanabe N; Aoyama A; Jinbo Y; Hayashi N
Biochemistry; 2008 Jul; 47(27):7158-66. PubMed ID: 18553937
[TBL] [Abstract][Full Text] [Related]
46. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator.
Gallay P; Swingler S; Aiken C; Trono D
Cell; 1995 Feb; 80(3):379-88. PubMed ID: 7859280
[TBL] [Abstract][Full Text] [Related]
47. Structural basis for targeting avian sarcoma virus Gag polyprotein to the plasma membrane for virus assembly.
Vlach J; Eastep GN; Ghanam RH; Watanabe SM; Carter CA; Saad JS
J Biol Chem; 2018 Dec; 293(49):18828-18840. PubMed ID: 30309983
[TBL] [Abstract][Full Text] [Related]
48. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
De Francesco MA; Baronio M; Fiorentini S; Signorini C; Bonfanti C; Poiesi C; Popovic M; Grassi M; Garrafa E; Bozzo L; Lewis GK; Licenziati S; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9972-7. PubMed ID: 12105273
[TBL] [Abstract][Full Text] [Related]
49. A novel nuclear export activity in HIV-1 matrix protein required for viral replication.
Dupont S; Sharova N; DéHoratius C; Virbasius CM; Zhu X; Bukrinskaya AG; Stevenson M; Green MR
Nature; 1999 Dec; 402(6762):681-5. PubMed ID: 10604476
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
51. Antimyristoylation of the gag proteins in the human immunodeficiency virus-infected cells with N-myristoyl glycinal diethylacetal resulted in inhibition of virus production.
Tashiro A; Shoji S; Kubota Y
Biochem Biophys Res Commun; 1989 Dec; 165(3):1145-54. PubMed ID: 2692561
[TBL] [Abstract][Full Text] [Related]
52. Nonsynonymous mutations within the human immunodeficiency virus type 1 p17 gene are clustered to sequences binding to the host human leukocyte antigen class I molecules.
Birk M; Vahlne A; Sönnerborg A; Sällberg M
AIDS Res Hum Retroviruses; 1998 Feb; 14(3):241-8. PubMed ID: 9491914
[TBL] [Abstract][Full Text] [Related]
53. HIV-1 p17 and IFN-gamma both induce fructose 1,6-bisphosphatase.
Besançon F; Just J; Bourgeade MF; Van Weyenbergh J; Solomon D; Guillozo H; Wietzerbin J; Cayre YE
J Interferon Cytokine Res; 1997 Aug; 17(8):461-7. PubMed ID: 9282826
[TBL] [Abstract][Full Text] [Related]
54. The HIV-1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane.
Jacobs E; Gheysen D; Thines D; Francotte M; de Wilde M
Gene; 1989 Jun; 79(1):71-81. PubMed ID: 2673935
[TBL] [Abstract][Full Text] [Related]
55. Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the budding site of HIV-1 Gag protein.
Gallina A; Mantoan G; Rindi G; Milanesi G
Biochem Biophys Res Commun; 1994 Nov; 204(3):1031-8. PubMed ID: 7980574
[TBL] [Abstract][Full Text] [Related]
56. Refined solution structure of p17, the HIV matrix protein.
Matthews S; Barlow P; Clark N; Kingsman S; Kingsman A; Campbell I
Biochem Soc Trans; 1995 Nov; 23(4):725-9. PubMed ID: 8654825
[No Abstract] [Full Text] [Related]
57. Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain.
Dalton AK; Ako-Adjei D; Murray PS; Murray D; Vogt VM
J Virol; 2007 Jun; 81(12):6434-45. PubMed ID: 17392361
[TBL] [Abstract][Full Text] [Related]
58. Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.
Morikawa Y; Hockley DJ; Nermut MV; Jones IM
J Virol; 2000 Jan; 74(1):16-23. PubMed ID: 10590086
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.
Andreassen H; Bohr H; Bohr J; Brunak S; Bugge T; Cotterill RM; Jacobsen C; Kusk P; Lautrup B; Petersen SB
J Acquir Immune Defic Syndr (1988); 1990; 3(6):615-22. PubMed ID: 2187072
[TBL] [Abstract][Full Text] [Related]
60. A myristoyl switch at the plasma membrane triggers cleavage and oligomerization of Mason-Pfizer monkey virus matrix protein.
Častorálová M; Sýs J; Prchal J; Pavlů A; Prokopová L; Briki Z; Hubálek M; Ruml T
Elife; 2024 Mar; 13():. PubMed ID: 38517277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
